Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181074098> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3181074098 endingPage "2816" @default.
- W3181074098 startingPage "2813" @default.
- W3181074098 abstract "Abstract Acquired von Willebrand disease (aVWD) is a rare disorder associated with a reduction in von Willebrand factor (VWF) activity, leading to increased bleeding risk. Monoclonal gammopathy of undetermined significance (MGUS) is the most common cause of lymphoproliferative disorder-associated aVWD and is caused by accelerated clearance of circulating VWF. Standard VWF replacement protocols for congenital VWD based on intermittent bolus dosing are typically less effective for aVWD because of antibody-mediated clearance. Intermittent bolus dosing of VWF concentrates often leads to inadequate peak response and profoundly shortened VWF half-life in aVWD. Intravenous immune globulin (IVIG) has demonstrated efficacy in aVWD; however, treatment effect is delayed up to 4 days, limiting its efficacy in acutely bleeding patients. We report the successful use of continuous-infusion VWF concentrate (with or without concomitant IVIG) in 3 patients with MGUS-associated aVWD who had demonstrated an inadequate response to bolus dosing. VWF concentrate doses required in this cohort were higher than typical doses for bleeding treatment in congenital VWD. This report illustrates that continuous-infusion VWF concentrate administration with or without intravenous immunoglobulin rapidly achieves target ristocetin cofactor activity and provides adequate hemostasis in aVWD associated with immunoglobulin G MGUS." @default.
- W3181074098 created "2021-07-19" @default.
- W3181074098 creator A5007450531 @default.
- W3181074098 creator A5010608741 @default.
- W3181074098 creator A5013326236 @default.
- W3181074098 creator A5047512989 @default.
- W3181074098 creator A5076437910 @default.
- W3181074098 creator A5082304508 @default.
- W3181074098 creator A5085582583 @default.
- W3181074098 creator A5090082947 @default.
- W3181074098 date "2021-07-16" @default.
- W3181074098 modified "2023-09-30" @default.
- W3181074098 title "Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease" @default.
- W3181074098 cites W1785732432 @default.
- W3181074098 cites W1963687340 @default.
- W3181074098 cites W2004684255 @default.
- W3181074098 cites W2092164518 @default.
- W3181074098 cites W2148690066 @default.
- W3181074098 cites W3035898119 @default.
- W3181074098 cites W3131788281 @default.
- W3181074098 cites W4317638974 @default.
- W3181074098 doi "https://doi.org/10.1182/bloodadvances.2021004843" @default.
- W3181074098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8341349" @default.
- W3181074098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34269797" @default.
- W3181074098 hasPublicationYear "2021" @default.
- W3181074098 type Work @default.
- W3181074098 sameAs 3181074098 @default.
- W3181074098 citedByCount "3" @default.
- W3181074098 countsByYear W31810740982022 @default.
- W3181074098 countsByYear W31810740982023 @default.
- W3181074098 crossrefType "journal-article" @default.
- W3181074098 hasAuthorship W3181074098A5007450531 @default.
- W3181074098 hasAuthorship W3181074098A5010608741 @default.
- W3181074098 hasAuthorship W3181074098A5013326236 @default.
- W3181074098 hasAuthorship W3181074098A5047512989 @default.
- W3181074098 hasAuthorship W3181074098A5076437910 @default.
- W3181074098 hasAuthorship W3181074098A5082304508 @default.
- W3181074098 hasAuthorship W3181074098A5085582583 @default.
- W3181074098 hasAuthorship W3181074098A5090082947 @default.
- W3181074098 hasBestOaLocation W31810740981 @default.
- W3181074098 hasConcept C126322002 @default.
- W3181074098 hasConcept C159654299 @default.
- W3181074098 hasConcept C203014093 @default.
- W3181074098 hasConcept C2777288759 @default.
- W3181074098 hasConcept C2778589496 @default.
- W3181074098 hasConcept C2778780528 @default.
- W3181074098 hasConcept C2779394231 @default.
- W3181074098 hasConcept C2779936836 @default.
- W3181074098 hasConcept C43376680 @default.
- W3181074098 hasConcept C71924100 @default.
- W3181074098 hasConcept C89560881 @default.
- W3181074098 hasConcept C90924648 @default.
- W3181074098 hasConceptScore W3181074098C126322002 @default.
- W3181074098 hasConceptScore W3181074098C159654299 @default.
- W3181074098 hasConceptScore W3181074098C203014093 @default.
- W3181074098 hasConceptScore W3181074098C2777288759 @default.
- W3181074098 hasConceptScore W3181074098C2778589496 @default.
- W3181074098 hasConceptScore W3181074098C2778780528 @default.
- W3181074098 hasConceptScore W3181074098C2779394231 @default.
- W3181074098 hasConceptScore W3181074098C2779936836 @default.
- W3181074098 hasConceptScore W3181074098C43376680 @default.
- W3181074098 hasConceptScore W3181074098C71924100 @default.
- W3181074098 hasConceptScore W3181074098C89560881 @default.
- W3181074098 hasConceptScore W3181074098C90924648 @default.
- W3181074098 hasIssue "14" @default.
- W3181074098 hasLocation W31810740981 @default.
- W3181074098 hasLocation W31810740982 @default.
- W3181074098 hasOpenAccess W3181074098 @default.
- W3181074098 hasPrimaryLocation W31810740981 @default.
- W3181074098 hasRelatedWork W184289008 @default.
- W3181074098 hasRelatedWork W2086293307 @default.
- W3181074098 hasRelatedWork W2095386883 @default.
- W3181074098 hasRelatedWork W2140279654 @default.
- W3181074098 hasRelatedWork W2143874699 @default.
- W3181074098 hasRelatedWork W2232953465 @default.
- W3181074098 hasRelatedWork W2397941862 @default.
- W3181074098 hasRelatedWork W2788609897 @default.
- W3181074098 hasRelatedWork W4234373395 @default.
- W3181074098 hasRelatedWork W77869146 @default.
- W3181074098 hasVolume "5" @default.
- W3181074098 isParatext "false" @default.
- W3181074098 isRetracted "false" @default.
- W3181074098 magId "3181074098" @default.
- W3181074098 workType "article" @default.